Assignee
KULEON LLC
US·6 granted patents·5 pending applications·6 citations·filing 2022–2025
Top patents by PatentIndex Score
11 records- 0194US11780807B2Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptorKULEON LLC·Filed 2023·Granted Oct 10, 2023·4 cites·30 claims
- 0293US12012380B1Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulatorsKULEON LLC·Filed 2023·Granted Jun 18, 2024·2 cites·30 claims
- 0393US2026092034A17-azaindole analogs and methods of treating neurological disorders using the sameKULEON LLC·Filed 2025·Application pending·0 cites
- 0487US12344582B2Mixed serotonin 5-HT2A/2C receptor agonists and methods for treating pain and depressionKULEON LLC·Filed 2024·Granted Jul 1, 2025·0 cites·30 claims
- 0586US12275701B2Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulatorsKULEON LLC·Filed 2024·Granted Apr 15, 2025·0 cites·22 claims
- 0684US12441683B27-methyl indole analogs and dosage forms containing the sameKULEON LLC·Filed 2025·Granted Oct 14, 2025·0 cites·20 claims
- 0784US12187678B2Methods of treating psychological disorders through the administration of serotonin 5-HT2C receptor modulatorsKULEON LLC·Filed 2023·Granted Jan 7, 2025·0 cites·34 claims
- 0881US2025340513A1Neuroplastogens and non-hallucinogenic serotonin 5-ht2a/2c receptor modulatorsKULEON LLC·Filed 2025·Application pending·0 cites
- 0965US2024294538A1Serotonin Receptor Agonists and Methods of Making and Using the SameKULEON LLC·Filed 2024·Application pending·0 cites
- 1059US2025145638A1Serotonin Receptor Agonists and Methods of Making and Using the SameKULEON LLC·Filed 2022·Application pending·0 cites
- 1153US2025289817A1Serotonin receptor modulators and methods of making and using the sameKULEON LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KULEON LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →